Back
Blueprint Medicines Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
58
BPMC
Blueprint Medicines
Last Price:
103.62
Seasonality Move:
6.04%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
129.25
Seasonality Move:
2.77%
Buy
58
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $104.26. The Score for BPMC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.83. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $104.26
The current trend is moderately bullish and BPMC is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.83
The current trend is moderately bearish and SRPT is experiencing slight buying pressure.
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.82 | Buy |
Relative Strength Index (14 RSI): | 58.18 | Buy |
Chaikin Money Flow: | -192013 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.81 - 107.43) | Buy |
Bollinger Bands (100): | (81.36 - 98.4) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.93 | Buy |
Relative Strength Index (14 RSI): | 54.45 | Buy |
Chaikin Money Flow: | 174334 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.1 - 134.22) | Buy |
Bollinger Bands (100): | (113.61 - 133.07) | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 106.42 | Sell |
20-day SMA: | 101.85 | Buy |
50-day SMA: | 94.71 | Buy |
200-day SMA: | 73.99 | Buy |
8-day EMA: | 105.47 | Sell |
20-day EMA: | 102.33 | Buy |
50-day EMA: | 96.35 | Buy |
200-day EMA: | 79.65 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.99 | Sell |
20-day SMA: | 130.38 | Buy |
50-day SMA: | 126.51 | Buy |
200-day SMA: | 113.64 | Buy |
8-day EMA: | 131.77 | Sell |
20-day EMA: | 130.2 | Buy |
50-day EMA: | 127.07 | Buy |
200-day EMA: | 118.36 | Buy |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
Blueprint Medicines Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |